Sample Page

MMDA-3a, also known as 2-methoxy-3,4-methylenedioxyamphetamine or as 2-methoxy-MDA, is a psychedelic drug of the amphetamine family.[1][2] It is the 2-methoxy derivative of 3,4-methylenedioxyamphetamine (MDA).[1] The drug produces hallucinogenic effects in humans.[1] Its dose is listed as 20 to 80 mg orally and its duration as 10 to 16 hours in Alexander Shulgin‘s book PiHKAL (Phenethylamines I Have Known and Loved).[1][2] A higher dose of 100 mg was also reportedly explored and doses of 80 to 100 mg were said to be very similar to 100 μg LSD.[1] The chemical synthesis of MMDA-3a has been described.[1][2] MMDA-3a is a positional isomer of MMDA and hence is a Schedule I controlled substance in the United States.[2] It is also a controlled substance in Canada under phenethylamine blanket-ban language.[3]

See also

References

  1. ^ a b c d e f g h Alexander T. Shulgin; Ann Shulgin (1991). “#134 MMDA-3a 2-METHOXY-3,4-METHYLENEDIOXYAMPHETAMINE”. PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. pp. 795–798. ISBN 978-0-9630096-0-9. OCLC 25627628.
  2. ^ a b c d e f Shulgin A, Manning T, Daley PF (2011). “#99. MMDA-3a”. The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press. pp. 240–241. ISBN 978-0-9630096-3-0. OCLC 709667010.
  3. ^ “Controlled Drugs and Substances Act”. Department of Justice Canada. Retrieved 19 January 2026.